Maharashtra Government has extended the time limit to file appeals before the Appellate Tribunal for orders communicated before April 1, 2026. The notification ensures taxpayers get a one-time relief window while maintaining standard timelines for new cases.
Form 12 provides certified details of R&D expenditure, enabling authorities to verify deduction claims under section 45(2).
Form 7, prescribed under Rule 30 of the Income-tax Rules, 2026, is a mandatory application for sponsors seeking prior approval of a scientific research programme under section 45(3)(c) of the Income-tax Act, 2025.
Form 2 filing is compulsory to obtain government notification for Zero Coupon Bonds. Without compliance, issuers risk losing critical tax benefits.
The new law preserves existing residency tests and tax benefits for NRIs. It ensures continuity without altering core provisions.
The new law retains the same appellate hierarchy and procedures. Taxpayers can expect consistency without disruption in appeal mechanisms.
The 2025 Act replaces multiple forms with simplified, category-specific formats. It streamlines compliance while retaining continuity for existing registrations.
The AAR held that medicines and consumables supplied during treatment are part of composite healthcare services. As the principal supply is exempt, the entire supply qualifies for GST exemption.
The appellate authority condoned an 18-day delay in filing a GST appeal, accepting illness of a key partner as sufficient cause. The case will now proceed for hearing on merits.
The government has retained existing tariff values for key imports like gold, silver, and edible oils. The update ensures valuation continuity without impacting import costs.
